132 related articles for article (PubMed ID: 38123348)
21. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
22. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma.
Dei Tos AP; Piccinin S; Doglioni C; Vukosavljevic T; Mentzel T; Boiocchi M; Fletcher CD
Am J Pathol; 1997 Dec; 151(6):1531-9. PubMed ID: 9403703
[TBL] [Abstract][Full Text] [Related]
23. Limited role of TP53 and TP53-related genes in myxoid liposarcoma.
Pilotti S; Lavarino C; Mezzelani A; Della Torre C; Minoletti F; Sozzi G; Azzarelli A; Rilke F; Pierotti MA
Tumori; 1998; 84(5):571-7. PubMed ID: 9862519
[TBL] [Abstract][Full Text] [Related]
24. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
[TBL] [Abstract][Full Text] [Related]
25. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
Narendra S; Valente A; Tull J; Zhang S
Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
[TBL] [Abstract][Full Text] [Related]
26. [Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation].
Lanckohr C; Kasprzynski A; Klein-Hitpass L; Homann HH; Lehnhardt M; Müller O; Kuhnen C; Herter P
Pathologe; 2010 Feb; 31(1):60-6. PubMed ID: 19823827
[TBL] [Abstract][Full Text] [Related]
27. Mixed-type liposarcoma: clinicopathological, immunohistochemical, and molecular analysis of a case arising in deep soft tissues of the lower extremity.
Mentzel T; Palmedo G; Hantschke M; Woziwodzki J; Beck C
Virchows Arch; 2008 Aug; 453(2):197-201. PubMed ID: 18551309
[TBL] [Abstract][Full Text] [Related]
28. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
29. Vulvar Myxoid Liposarcoma and Well Differentiated Liposarcoma With Molecular Cytogenetic Confirmation: Case Reports With Review of Malignant Lipomatous Tumors of the Vulva.
Schoolmeester JK; Leifer AJ; Wang L; Hameed MR
Int J Gynecol Pathol; 2015 Jul; 34(4):390-5. PubMed ID: 25851712
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.
de Graaff MA; Yu JS; Beird HC; Ingram DR; Nguyen T; Juehui Liu J; Bolshakov S; Szuhai K; Åman P; Torres KE; Lev D; Nielsen TO; Bovée JV; Lazar AJ; Somaiah N
Lab Invest; 2016 Aug; 96(8):885-94. PubMed ID: 27270875
[TBL] [Abstract][Full Text] [Related]
31. Myxoid liposarcoma with transition to round-cell lesion-cell cycle regulator genes and telomerase activity characterizing tumor progression: a case report.
Jaeger V; Schneider-Stock R; Gerresheim F; Epplen JT; Serra M; Lippert H; Roessner A
Hum Pathol; 1999 Dec; 30(12):1515-9. PubMed ID: 10667432
[TBL] [Abstract][Full Text] [Related]
32. Primary Retroperitoneal Myxoid Liposarcomas.
Setsu N; Miyake M; Wakai S; Nakatani F; Kobayashi E; Chuman H; Hiraoka N; Kawai A; Yoshida A
Am J Surg Pathol; 2016 Sep; 40(9):1286-90. PubMed ID: 27158758
[TBL] [Abstract][Full Text] [Related]
33. Expression of CTAG1B clone EPR13780 versus
Abdelaziz MM; Tayel HY; Abdel-Bary A; Badawy OM
J Histotechnol; 2022 Jun; 45(2):56-65. PubMed ID: 34845972
[TBL] [Abstract][Full Text] [Related]
34. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
35. Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: report of a case and review of the literature.
Tajima S; Koda K
Med Mol Morphol; 2017 Jun; 50(2):112-116. PubMed ID: 25986682
[TBL] [Abstract][Full Text] [Related]
36. Liposarcoma: Multimodality Management and Future Targeted Therapies.
Crago AM; Dickson MA
Surg Oncol Clin N Am; 2016 Oct; 25(4):761-73. PubMed ID: 27591497
[TBL] [Abstract][Full Text] [Related]
37. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
[TBL] [Abstract][Full Text] [Related]
38. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
[TBL] [Abstract][Full Text] [Related]
39. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases.
Sioletic S; Dal Cin P; Fletcher CD; Hornick JL
Histopathology; 2013 Jan; 62(2):287-93. PubMed ID: 23020289
[TBL] [Abstract][Full Text] [Related]
40. Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis.
de Vreeze RS; de Jong D; Koops W; Nederlof PM; Ariaens A; Haas RL; van Coevorden F
Int J Cancer; 2011 Feb; 128(4):778-86. PubMed ID: 20473880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
